SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " metastatic " 15 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
QUEENSBURY, N.Y., May 07, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the first quarter ended March 31, 2026.
Med Center Health first in region to offer new prostate cancer treatment
Med Center Health is the first hospital in the region, and the seventh in the state, to offer a new treatment for patients with metastatic prostate cancer.
COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings
Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...
Heart health enters the future with a $28.7 million gift from the Marcus Foundation
Related News USC Stem Cell welcomes new leader, renowned physician-scientist Chuck Murry August 20, 2024 An early blood test can predict survival in patients with metastatic prostate cancer, shows USC […]
A 20-year-old cancer vaccine may hold the key to long-term survival
Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key immune signal called CD27, researchers dramatically improved tumor elimination in lab studies. The findings suggest cancer vaccines may have been missing a crucial ingredient all along.
Doctors thought man had brain cancer — they found live tapeworms instead
Doctors suspected metastatic brain cancer in a 60-year-old man, but scans revealed pork tapeworm larvae causing neurocysticercosis.
When you have advanced prostate cancer: What living with the disease looks like
President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to manage this advanced prostate cancer.
13 years ago, a young Rostraver mom prepared to die; the ‘super responder’ now shows no signs of cancer
In 2013, 28-year-old Kate Crawford threw herself into preparing for her death. She had a fresh diagnosis of metastatic breast cancer, an estimated 18 to...
IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing...
Bart Story Dies: Veteran Entertainment Research Executive Was 63
Bart Story, a veteran entertainment research executive best known for his work at MarketCast and SAG-AFTRA, has died. He was 63. Story died on December 23, 2025, in Los Angeles from complications related to metastatic urothelial carcinoma. The executive spent more than three decades helping studios and streamers better understand audiences. Since 2003, he served …
Advocates push for passage of Metastatic Breast Cancer Access to Care Act
Advocates with the National Breast Cancer Coalition hope Congress will move the bipartisan measure forward.
A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy
This could save lives.
Nathan J. Nordmann, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spinal Oncology and Co-Director of Spinal Radiosurgery
August 27, 2026 – Fellowship-trained neurosurgeon Nathan J. Nordmann, M.D., has joined Baptist Health Miami Neuroscience as director of spinal oncology and co-director of spinal radiosurgery. He specializes in the surgical treatment of conditions affecting the brain and spine, with advanced expertise in primary and metastatic spinal tumors, complex spinal pathology and minimally invasive surgical techniques. […]
COMMENTARY: Science, Not Politics, Must Guide Lifesaving Medical Research
AFRO-AMERICAN – WASHINGTON — A recent announcement regarding a new treatment for metastatic pancreatic cancer, daraxonrasib, has shown it doubled survival rates for patients and reduced the risk of death by 60 percent. This breakthrough stemmed from sustained, peer-reviewed scientific investment.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.